NCT02262819View on ClinicalTrials.gov

Human Immunity Against Staphylococcus Aureus Skin Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

October 10, 2014

Primary Completion Date

April 24, 2019

Study Completion Date

April 24, 2019

Conditions
Staphylococcus Aureus Skin Infection
Interventions
DRUG

S. aureus

S. aureus, commensal coagulase-negative staphylococcal species, and Gram-negative commensals, such as Roseomonas and Pseudomonas species

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02262819 - Human Immunity Against Staphylococcus Aureus Skin Infection | Biotech Hunter | Biotech Hunter